NRD
BSX icon

Nebula Research & Development’s Boston Scientific BSX Stock Holding History

Nebula Research & Development’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,018
Closed -$1.08M – 134
2025
Q2 		$1.08M Sell
10,018
-31,526
-76% -$3.19M 0.09% 378
2025
Q1 		$4.19M Buy
41,544
+30,848
+288% +$3.11M 0.39% 34
2024
Q4 		$955K Buy
10,696
+2,161
+25% +$190K 0.11% 309
2024
Q3 		$715K Buy
+8,535
New +$673K 0.09% 436

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nebula Research & Development's BSX Position: Q3 2025 in Review

Nebula Research & Development sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 10,018 shares — an estimated $1.08M sold.

Nebula Research & Development first reported a position in BSX in Q3 2024 and held it in 4 quarters. The position peaked at $4.19M in Q1 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Nebula Research & Development reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 10,018 Boston Scientific shares in Q3 2025, an estimated $1.08M.
  • Nebula Research & Development first reported a position in Boston Scientific in Q3 2024 and held it in 4 quarters.
  • Nebula Research & Development's Boston Scientific position peaked at $4.19M in Q1 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.